141 related articles for article (PubMed ID: 34903987)
1. Application of QSAR Method in the Design of Enhanced Antimalarial Derivatives of Azetidine-2-carbonitriles, their Molecular Docking, Drug-likeness, and SwissADME Properties.
Ibrahim ZY; Uzairu A; Shallangwa GA; Abechi SE
Iran J Pharm Res; 2021; 20(3):254-270. PubMed ID: 34903987
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling and design of some β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against chloroquine sensitive, 3D7 strain of
Ibrahim ZY; Uzairu A; Shallangwa GA; Abechi SE
Heliyon; 2021 Jan; 7(1):e05924. PubMed ID: 33553724
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit
Maetani M; Kato N; Jabor VAP; Calil FA; Nonato MC; Scherer CA; Schreiber SL
ACS Med Chem Lett; 2017 Apr; 8(4):438-442. PubMed ID: 28435533
[TBL] [Abstract][Full Text] [Related]
4. Theoretical design of novel antimalarial agents against
Ibrahim ZY; Uzairu A; Shallangwa G; Abechi S
Heliyon; 2020 Sep; 6(9):e05032. PubMed ID: 33015389
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening and molecular dynamic simulations of the antimalarial derivatives of 2-anilino 4-amino substituted quinazolines docked against a
Ibrahim ZY; Uzairu A; Shallangwa GA; Abechi SE; Isyaku S
Egypt J Med Hum Genet; 2022; 23(1):119. PubMed ID: 37521844
[TBL] [Abstract][Full Text] [Related]
6. QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds.
Mahmud AW; Shallangwa GA; Uzairu A
Heliyon; 2020 Mar; 6(3):e03449. PubMed ID: 32154412
[TBL] [Abstract][Full Text] [Related]
7. Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel
Ghosh S; Chetia D; Gogoi N; Rudrapal M
BioTechnologia (Pozn); 2021; 102(3):257-275. PubMed ID: 36606151
[TBL] [Abstract][Full Text] [Related]
8. Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies.
Ja'afaru SC; Uzairu A; Chandra A; Sallau MS; Ndukwe GI; Ibrahim MT; Qamar I
J Taibah Univ Med Sci; 2024 Apr; 19(2):429-446. PubMed ID: 38440085
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling.
Abdullahi SH; Uzairu A; Shallangwa GA; Uba S; Umar AB
J Egypt Natl Canc Inst; 2023 Aug; 35(1):24. PubMed ID: 37544974
[TBL] [Abstract][Full Text] [Related]
11. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
12. QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against
Adeniji SE; Uba S; Uzairu A
J Pathog; 2018; 2018():1018694. PubMed ID: 29862081
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents.
Hadni H; Elhallaoui M
Heliyon; 2020 Apr; 6(4):e03580. PubMed ID: 32322700
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking and QSAR studies for modeling the antimalarial activity of hybrids 4-anilinoquinoline-triazines derivatives with the wild-type and mutant receptor
Hadni H; Elhallaoui M
Heliyon; 2019 Aug; 5(8):e02357. PubMed ID: 31485537
[No Abstract] [Full Text] [Related]
15. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR, molecular docking, DFT and ADMET studies on quinazoline derivatives to explore novel DHFR inhibitors.
Hadni H; Bakhouch M; Elhallaoui M
J Biomol Struct Dyn; 2023 Jan; 41(1):161-175. PubMed ID: 34825630
[TBL] [Abstract][Full Text] [Related]
17. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines.
Singh B; Vishwakarma RA; Bharate SB
Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933
[TBL] [Abstract][Full Text] [Related]
18. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
Hou X; Chen X; Zhang M; Yan A
SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of
Ibrahim ZY; Uzairu A; Shallangwa GA; Abechi SE; Isyaku S
J Taibah Univ Med Sci; 2023 Dec; 18(6):1200-1216. PubMed ID: 37250808
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents.
Abdullahi SH; Uzairu A; Shallangwa GA; Uba S; Umar AB
J Taibah Univ Med Sci; 2023 Oct; 18(5):1018-1029. PubMed ID: 36959916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
